There are several technologies used for multiplexing in cancer research:
- Next-Generation Sequencing (NGS): NGS allows for the simultaneous sequencing of multiple DNA or RNA samples, enabling the detection of genetic mutations, gene expression levels, and other genomic alterations. - Mass Spectrometry: This technique can simultaneously quantify multiple proteins and metabolites, providing insights into the proteomic and metabolic landscape of cancer cells. - Multiplex Immunohistochemistry (IHC): Multiplex IHC can detect multiple proteins within a single tissue section, aiding in the characterization of tumor heterogeneity and immune cell infiltration. - Flow Cytometry: Flow cytometry can analyze multiple cell surface and intracellular markers in individual cells, making it invaluable for studying cell populations and signaling pathways in cancer.
